Related Experiment Video
Updated: Feb 23, 2026

10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
11.2K
Epidemiology of Multiple Sclerosis in Austria
Sabine Salhofer-Polanyi1, Hakan Cetin, Fritz Leutmezer
1Clinic for Neurology 2, Med Campus III, Kepler University Clinic Linz, Linz, Austria.
Neuroepidemiology
|August 30, 2017
Summary
This study determined the incidence and prevalence of multiple sclerosis (MS) in Austria, finding rates at the higher end compared to other European nations and the US.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with significant public health implications.
- Understanding the epidemiology of MS is crucial for resource allocation and healthcare planning.
Purpose of the Study:
- To determine the incidence rate and prevalence ratio of multiple sclerosis (MS) in Austria.
- To provide updated epidemiological data on MS within the Austrian population.
Main Methods:
- Utilized hospital discharge diagnoses and MS-specific immunomodulatory treatment prescriptions.
- Employed the capture-recapture method for incidence and prevalence estimation.
- Data encompassed 98% of Austrian citizens with health insurance.
Main Results:
- Extracted data from 1,392,629 medication prescriptions and 40,956 hospitalizations, identifying 13,205 MS patients.
- Calculated an MS incidence rate of 19.5/100,000 person-years and a prevalence ratio of 158.9/100,000.
- Observed a female to male ratio of 1.6 for incidence and 2.2 for prevalence.
Conclusions:
- MS incidence and prevalence in Austria fall within the upper range of reported figures from European countries and the United States.
- The findings highlight the significant burden of MS in Austria.
- These epidemiological data are essential for informing national healthcare strategies and research efforts.
More Related Videos
Related Concept Videos
Prevalence and Incidence
2.0K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.0K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
608
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
608
Statistical Methods for Analyzing Epidemiological Data
1.1K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.1K
Genome-wide Association Studies-GWAS
15.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.9K

